Updated:
Riverfront Ventures
Riverfront Ventures is a venture capital firm investing in early-stage companies in southwestern Pennsylvania. They have made 33 investments, including a...
Riverfront Ventures
Riverfront Ventures is a venture capital firm investing in early-stage companies in southwestern Pennsylvania. They have made 33 investments, including a Series A investment in Handl Health on January 13, 2026. The firm has facilitated 5 portfolio exits, with ALung Technologies exiting on May 05, 2022.
General information
Firm type
Venture Capital
Year founded
2013
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Pittsburgh
Corporate office
Innovation Works, Inc. One Allegheny Square, Nova Tower 1, Suite 401, Pittsburgh, PA 15212
Principals
Kirk Botula
Managing Partner
Gary Glausser
Managing Partner
Rich Lunak
Managing Partner
Ven Raju
Managing Partner
Cigdem Benam
Managing Partner
Jeffrey McDaniel
Managing Partner
Afshan Khan
Managing Partner
Larry Miller
Managing Partner
Sophie Burkholder
Investment Team
Sector focus
Frequently asked questions
What is the relationship between Riverfront Ventures and Innovation Works?
Riverfront Ventures is the venture capital arm of Innovation Works, a Pittsburgh-based nonprofit. Innovation Works runs four accelerators — AlphaLab, AlphaLab Gear, AlphaLab Health, and the Robotics Factory — and operates one of the country's most active seed funds. Riverfront provides follow-on capital to companies that have graduated from Innovation Works' programs, allowing the combined entity to support startups from pre-seed through growth stage.
How does Riverfront Ventures source its deal flow?
Nearly all of Riverfront's deal flow originates from Innovation Works' ecosystem. Innovation Works has invested over $70 million in more than 270 companies over 15 years, acting as a primary feeder. Riverfront then selects the most promising early-growth-stage companies from this pipeline for follow-on investment, often co-investing with top-tier venture firms from outside the region.
Does Riverfront Ventures invest outside of Pittsburgh?
Riverfront's public mandate is focused on high-growth early-stage companies located primarily in southwestern Pennsylvania. While the firm may consider opportunities that have a meaningful connection to the region, its core mission is to commercialize Pittsburgh-born technology and bring national co-investors into local deals.
What is the typical check size for a Riverfront Ventures investment?
Riverfront's initial investment typically ranges from $500,000 to $750,000, with a similar amount reserved for follow-on. The total investment per company generally falls between $1 million and $1.5 million. The firm functions as a committed early-growth-stage partner rather than a seed-stage lead, usually entering after Innovation Works has provided the initial startup funding.
Who makes investment decisions at Riverfront Ventures?
Investment decisions are made collectively by the firm's Managing Partners, an eight-person group that includes Kirk Botula, Gary Glausser, Rich Lunak, Ven Raju, Cigdem Benam, Jeffrey McDaniel, Afshan Khan, and Larry Miller. The partners combine experience as former technology operators and venture investors across more than 275 companies and nine funds.
Is Riverfront Ventures a single family office or an institutional venture firm?
Riverfront Ventures is an institutional venture capital firm structured as the for-profit investment arm of the nonprofit Innovation Works. It is not a family office. The firm raises external capital and co-invests with other institutional venture firms, using Innovation Works' accelerator and seed-fund infrastructure as its proprietary sourcing advantage.
What sectors does Riverfront Ventures target?
The firm targets a broad set of technology sectors with large market potential, including software, life sciences, robotics, advanced materials, AI, healthcare, enterprise SaaS, mobility, and energy. Its portfolio includes companies like Aspinity (analog ML chips), Gridwise (gig mobility), Maven (fleet management), and Complexa (biotech), reflecting this multi-sector approach.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: